
|Articles|April 1, 2004
Anticholinergic appears to reduce urgency severity
Florence, Italy--The anticholinergic drug trospium chloride seemsto reduce urgency severity among patients with overactive bladder, accordingto the results of a prospective investigation by researchers from NorthwesternUniversity, Feinberg School of Medicine, Evanston, IL.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5










